Microwave Ablation Market: Rising Prevalence of Cancer to Drive Market Growth to US$ 4,399.7 Million by 2033

As per the latest market research by Business Market Insights (BMI), the research report " Microwave Ablation Market Size and Forecast (2025–2033)" forecasts how the market is set to surge 100.7% by 2033. The global microwave ablation market is driven by the increasing incidence of cancer and the growing demand for minimally invasive tumor therapies. Rising preference for image-guided, percutaneous procedures over traditional surgical interventions is accelerating adoption. Expanding clinical applications across liver, lung, and kidney tumors, along with continuous advancements in microwave generator technology and antenna designs, are further supporting sustained market growth.

The report forecasts the market to expand from US$ 2,192.4 million in 2025 to US$ 4,399.7 million by 2033, registering a robust CAGR of 9.3% over the 2026–2033 period.

The global microwave ablation market represents a critical segment of minimally invasive oncology therapies, providing targeted tissue destruction for tumor management. These procedures are primarily applied in the treatment of liver, lung, kidney, and bone tumors, with patient populations including individuals with primary or metastatic cancers unsuitable for surgical resection. Market expansion is driven by the increasing prevalence of cancer, aging demographics, and accumulating clinical evidence demonstrating the efficacy and safety of microwave ablation compared to conventional therapies. Advances in antenna design, real-time imaging integration, and energy delivery systems have improved procedural accuracy and reduced complications. Emerging trends such as combination therapies, expanding clinical indications, and enhanced adoption in developing regions are further supporting market growth, alongside ongoing investments in interventional oncology infrastructure.

Overview of report findings

Market Growth

The microwave ablation market is projected to grow from US$ 2,192.4 million in 2025 to US$ 4,399.7 million by 2033, registering a compound annual growth rate (CAGR) of 9.3% between 2026 and 2033.

The global microwave ablation market is driven by the increasing incidence of cancer and the growing demand for minimally invasive tumor therapies. Rising preference for image-guided, percutaneous procedures over traditional surgical interventions is accelerating adoption. Expanding clinical applications across liver, lung, and kidney tumors, along with continuous advancements in microwave generator technology and antenna designs, are further supporting sustained market growth.

Rising Prevalence of Cancer

The rising prevalence of cancer is a significant driver of the global microwave ablation market. Malignancies such as hepatocellular carcinoma, metastatic liver tumors, non-small cell lung cancer, renal cell carcinoma, and certain bone tumors are increasing steadily due to aging populations, longer life expectancy, environmental exposure, and lifestyle-related risk factors such as smoking, obesity, alcohol consumption, chronic hepatitis infections, and sedentary behavior. Improved access to advanced diagnostic tools, including high-resolution computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), ultrasound imaging, and molecular tumor profiling technologies, has enhanced early identification and precise staging of cancer cases. As the global cancer burden continues to rise, healthcare systems face mounting demand for effective, durable, and minimally invasive tumor treatment options. Microwave ablation provides a targeted therapeutic approach by delivering controlled electromagnetic energy to generate heat and induce coagulative necrosis in malignant tissue, particularly in patients who are not eligible for surgical resection or who are unresponsive to systemic therapies. Expanding clinical evidence, updated oncology treatment guidelines, and growing physician expertise are accelerating adoption of microwave ablation across hepatic, pulmonary, renal, and palliative oncology applications. Concurrently, ongoing research and technological advancements, such as high-powered microwave generators, multi-antenna systems, improved thermal monitoring, and image-guided navigation platforms, are expanding the eligible patient population and improving treatment precision. The sustained increase in diagnosed cancer cases directly supports long-term demand for microwave ablation procedures globally, with rising procedure volumes and expanding oncology infrastructure investments further reinforcing market growth across developed and emerging healthcare systems.

Shift Toward Minimally Invasive Procedures

The growing shift toward minimally invasive procedures is a key factor propelling the global microwave ablation market. Patients and healthcare providers increasingly prefer treatment approaches that reduce surgical trauma, shorten hospital stays, minimize complications, and accelerate recovery times. Many solid tumors, particularly in the liver, lung, and kidney, can be effectively treated using percutaneous or laparoscopic microwave ablation techniques under image guidance. Microwave ablation delivers controlled thermal energy directly to the tumor site, minimizing damage to surrounding healthy tissue and reducing the need for open surgery. This minimally invasive approach lowers procedural risks, decreases anesthesia exposure, and supports faster post-procedural recovery, making it especially suitable for elderly patients and individuals with comorbidities such as cirrhosis, cardiovascular disease, diabetes, or respiratory impairment. Rising awareness among oncologists, interventional radiologists, and patients regarding the clinical and economic benefits of MWA is driving global adoption. Continuous technological innovations, including real-time imaging integration, multiple-antenna systems for larger tumor volumes, and improved energy delivery control are enhancing procedural safety, precision, and reproducibility. Healthcare systems are increasingly prioritizing cost-effective therapies that reduce inpatient admissions and improve patient quality of life. As minimally invasive oncology treatments continue to gain prominence and become incorporated into multidisciplinary cancer care models, demand for microwave ablation systems is expected to grow across North America, Europe, Asia Pacific, and other emerging regions, supporting sustained expansion of the global market.

Geographic Insights

North America leads the microwave ablation market owing to the high prevalence of cancer, particularly liver, lung, and kidney tumors, well-established oncology care infrastructure, and early adoption of advanced minimally invasive technologies. Strong reimbursement frameworks, high procedural volumes, and widespread availability of specialized cancer centers drive sustained market expansion. The presence of major medical device manufacturers, continuous clinical research, and streamlined regulatory pathways further accelerate the adoption of microwave ablation systems across leading healthcare institutions regionwide.

Europe ranks as the second-largest microwave ablation market, supported by aging populations, rising cancer incidence, and comprehensive public healthcare systems. Countries such as Germany, France, and the United Kingdom demonstrate strong interventional oncology programs and growing preference for image-guided, minimally invasive tumor ablation procedures. Favorable clinical guidelines, expanding reimbursement coverage, and ongoing technological advancements contribute to steady market growth for microwave ablation therapies across the region.

Asia Pacific is the fastest-growing region in the microwave ablation market due to its large patient pool, increasing cancer burden, and improving access to advanced treatment options. Expanding healthcare investments, rapid development of hospital infrastructure, and growing expertise in interventional radiology are driving adoption. China, India, and Southeast Asian countries are witnessing accelerated uptake supported by government healthcare initiatives, rising awareness of early tumor treatment, and increasing demand for cost-effective, minimally invasive oncology solutions across emerging healthcare markets regionwide.

Market Segmentation

• By product type, the microwave ablation market is segmented into microwave generator, antenna, and consumables & accessories. The antenna segment dominated the market in 2025. There is a recurring need for high-performance, precise antennas in MWA procedures, which are essential for effective thermal ablation of tumors, making them a key revenue driver for manufacturers.
• Based on application, the microwave ablation market is classified into cardiology, oncology, gynecology, urology, and others. The oncology segment dominated the market in 2025. Oncology applications lead because of a rising prevalence of cancer cases, increasing preference for minimally invasive tumor ablation techniques, and growing awareness among healthcare providers about the effectiveness of MWA in treating liver, lung, and other solid tumors.
• In terms of end user, the microwave ablation market is categorized into hospitals, specialty clinics, and ambulatory surgical centers. The hospitals segment dominated the market in 2025. Hospitals maintain a stronghold due to their well-established oncology and surgical departments, access to advanced MWA equipment, trained interventional radiologists and staff, and the capability to manage complex ablation procedures with comprehensive patient care.

Competitive Strategy & Development

Key Players: The microwave ablation market is populated by several key players, each contributing to its growth and innovation. Some prominent players are:

1. Siemens Healthineers AG
2. Johnson & Johnson
3. Medtronic
4. Mermaid Medical
5. Creo Medical
6. AngioDynamics
7. Terumo Corporation
8. Emblation Ltd.
9. Hygea Medical Technology Co., Ltd. 
10. ECO Medical

Trending Topics: Percutaneous Microwave Ablation Probes, Laparoscopic Microwave Ablation Systems, Antenna-Based Microwave Ablation Catheters, High-Power Microwave Generators, Coaxial Microwave Ablation Needles, Ultrasound-Guided Microwave Ablation Devices, CT-Guided Microwave Ablation Devices, MRI-Compatible Microwave Ablation Probes, Balloon-Integrated Microwave Ablation Catheters, Microwave Ablation Accessories and Consumables, Thermal Monitoring Microwave Sensors

Global Headlines

• Creo Medical Group plc first clinical robotic‑guided microwave ablation lung cases under Intuitive collaboration– In January 2025, clinical cases of robotic‑guided microwave ablation for lung cancer commenced at a UK hospital under an expanded collaboration with Intuitive’s Ion Endoluminal System, supporting future commercial rollout and evidence collection.
• Varian Medical Systems, Inc. received FDA 510(k) clearance for its IntelliBlate Microwave Ablation System– In July 2024, Varian (a Siemens Healthineers company) secured U.S. FDA clearance for its IntelliBlate microwave ablation platform for soft tissue ablation, designed to enable controlled ablation zones with modular probe options.
• Hygea Medical Technology Co., Ltd. obtained FDA approval for its microwave ablation system (EXCEED™ & EXACT™ probes)– In January 2024, the company’s EXCEED™ microwave treatment system and EXACT™ series microwave ablation probes received U.S. FDA approval, building on prior NMPA clearance in China and expanding indications for solid soft tissue tumors.

Conclusion

The global microwave ablation market demonstrates strong growth potential, driven primarily by rising incidence of chronic diseases, increasing preference for minimally invasive therapies, and expanding adoption in oncology and cardiology. Continuous technological innovations, including improved antenna designs, real-time imaging integration, and enhanced energy delivery systems, are expected to accelerate procedure efficiency and broaden clinical applications. Regionally, North America and Western Europe represent stable, mature markets, whereas the Asia-Pacific and Latin American regions exhibit high-growth prospects fueled by rising healthcare expenditure and expanding access to advanced medical technologies. Favorable reimbursement frameworks, evolving clinical guidelines, and supportive regulatory landscapes further underpin market expansion.